Seeing Is Believing
Currently out of the existing stock ratings of Matthew Caufield, 155 are a BUY (89.6%), 18 are a HOLD (10.4%).
Analyst Matthew Caufield, carries an average stock price target met ratio of 29.4% that have a potential upside of 32.24% achieved within 75 days.
Matthew Caufield’s has documented 311 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on KOD, Kodiak Sciences at 17-Aug-2026.
Analyst best performing recommendations are on EYEN (EYENOVIA).
The best stock recommendation documented was for ALDX (ALDEYRA THE) at 3/18/2026. The price target of $2 was fulfilled within 5 days with a profit of $0.58 (40.85%) receiving and performance score of 81.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Nov-2022
$2
$0.52 (35.14%)
$10
Buy Since 04-Nov-2021
$9
$7.52 (508.11%)
$9
Buy Since 30-Oct-2020
$7
$5.52 (372.97%)
$6
Buy Since 28-Mar-2024
$9
$7.52 (508.11%)
Buy Since 26-Jan-2015
$11
$9.52 (643.24%)
$30
Which stock is Matthew Caufield is most bullish on?
Which stock is Matthew Caufield is most reserved on?
What Year was the first public recommendation made by Matthew Caufield?